A structured literature review to determine the use of the American Society for Therapeutic Radiology and Oncology consensus definition of biochemical failure

作者: Kevin P McMullen , W.Robert Lee

DOI: 10.1016/S0090-4295(02)02259-8

关键词:

摘要: Abstract Objectives The American Society for Therapeutic Radiology and Oncology consensus definition (ACD) of biochemical failure after radiotherapy prostate cancer requires three consecutive prostate-specific antigen increases from a nadir value. members the Consensus Panel recognized that timing frequency determinations could affect comparability among different reports if this was used. For reason, recommended guidelines studies presented publication (publication [PGs]). present analysis examined extent to which ACD has been used in peer-reviewed published literature how frequently PGs have followed. Methods A structured review 10 relevant journals done. inclusion criteria required calendar year 1999 or 2000; treatment with external beam and/or brachytherapy previously untreated, nonmetastatic cancer; use antigen–defined disease-free endpoint. standardized checklist created completed by both authors. We independently reviewed each determine whether were Discrepancies between us resolved joint question achieve consensus. Results Fifty-seven articles met criteria. median number patients 302 (range 22 2222). followed 37 (64.9%) 57 articles. None all PGs. In five (8.7%), two vast majority (52 57, 91.3%) one none Panel. Conclusions thirds much less frequently. Consistent standards reporting not uniformly applied manuscripts.

参考文章(70)
Potters L, Zelefsky M, Venkatraman E, Oshinsky G, Leibel S, Cha C, Risk profiles to predict PSA relapse-free survival for patients undergoing permanent prostate brachytherapy. The cancer journal from Scientific American. ,vol. 5, pp. 301- ,(1999)
Alan Pollack, Gunar K. Zagars, Lewis G. Smith, J. Jack Lee, Andrew C. von Eschenbach, John A. Antolak, George Starkschall, Isaac Rosen, Preliminary Results of a Randomized Radiotherapy Dose-Escalation Study Comparing 70 Gy With 78 Gy for Prostate Cancer Journal of Clinical Oncology. ,vol. 18, pp. 3904- 3911 ,(2000) , 10.1200/JCO.2000.18.23.3904
Larry L. Kestin, Alvaro A. Martinez, Jannifer S. Stromberg, Gregory K. Edmundson, Gary S. Gustafson, Donald S. Brabbins, Peter Y. Chen, Frank A. Vicini, Matched-Pair Analysis of Conformal High–Dose-Rate Brachytherapy Boost Versus External-Beam Radiation Therapy Alone for Locally Advanced Prostate Cancer Journal of Clinical Oncology. ,vol. 18, pp. 2869- 2880 ,(2000) , 10.1200/JCO.2000.18.15.2869
Robert H. Liebross, Alan Pollack, Scott P. Lankford, Gunar K. Zagars, Andrew C. von Eschenbach, Fady B. Geara, Transrectal ultrasound for staging prostate carcinoma prior to radiation therapy: an evaluation based on disease outcome. Cancer. ,vol. 85, pp. 1577- 1585 ,(1999) , 10.1002/(SICI)1097-0142(19990401)85:7<1577::AID-CNCR20>3.0.CO;2-G
Jan J Battermann, I-125 implantation for localized prostate cancer: the Utrecht University experience. Radiotherapy and Oncology. ,vol. 57, pp. 269- 272 ,(2000) , 10.1016/S0167-8140(00)00287-5
Richard S. Cox, Irving D. Kaplan, Malcolm A. Bagshaw, Prostate-specific antigen kinetics after external beam irradiation for carcinoma of the prostate International Journal of Radiation Oncology*Biology*Physics. ,vol. 28, pp. 23- 31 ,(1994) , 10.1016/0360-3016(94)90137-6
Alan Pollack, Lewis G Smith, Andrew C von Eschenbach, EXTERNAL BEAM RADIOTHERAPY DOSE RESPONSE CHARACTERISTICS OF 1127 MEN WITH PROSTATE CANCER TREATED IN THE PSA ERA International Journal of Radiation Oncology Biology Physics. ,vol. 48, pp. 507- 512 ,(2000) , 10.1016/S0360-3016(00)00620-9
Michael K Brawer, Roger S Kirby, Claus G Roehrborn, Prostate Specific Antigen ,(2001)
Phillippe Nickers, Luc Coppers, Marc Beauduin, Marcel Darimont, Jean de Leval, Jean-Marie Deneufbourg, Feasibility study combining low dose rate 192Ir brachytherapy and external beam radiotherapy aiming at delivering 80–85 Gy to prostatic adenocarcinoma Radiotherapy and Oncology. ,vol. 55, pp. 41- 47 ,(2000) , 10.1016/S0167-8140(00)00142-0
John C. Blasko, Peter D. Grimm, John E. Sylsvester, William Cavanagh, The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma. Radiotherapy and Oncology. ,vol. 57, pp. 273- 278 ,(2000) , 10.1016/S0167-8140(00)00288-7